Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)
CUSIP: 23954D109
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 103,269,345
- Total 13F shares
- 19,043,827
- Share change
- +1,355,861
- Total reported value
- $450,147,328
- Price per share
- $23.73
- Number of holders
- 43
- Value change
- +$32,649,130
- Number of buys
- 29
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 23954D109?
CUSIP 23954D109 identifies DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23954D109:
Top shareholders of DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.8%
|
4,965,588
|
$113,066,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
2.2%
|
2,312,450
|
$52,655,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
1,505,396
|
$33,434,000 | — | 30 Jun 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
1.3%
|
1,341,396
|
$30,544,000 | — | 30 Jun 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.3%
|
1,297,770
|
$27,862,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.2%
|
1,189,943
|
$27,095,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
0.89%
|
918,975
|
$20,925,000 | — | 30 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.79%
|
818,980
|
$18,648,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.73%
|
756,047
|
$17,215,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.6%
|
619,384
|
$14,104,000 | — | 30 Jun 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.5%
|
518,966
|
$11,817,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
434,423
|
$9,892,000 | — | 30 Jun 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.36%
|
373,739
|
$8,510,000 | — | 30 Jun 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.2%
|
202,500
|
$4,611,000 | — | 30 Jun 2021 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.1%
|
103,717
|
$2,362,000 | — | 30 Jun 2021 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.1%
|
103,200
|
$2,350,000 | — | 30 Jun 2021 | |
| LMR Partners LLP |
13F
|
Company |
0.05%
|
50,000
|
$1,139,000 | — | 30 Jun 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.04%
|
41,147
|
$937,000 | — | 30 Jun 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.04%
|
37,069
|
$844,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
34,935
|
$795,000 | — | 30 Jun 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
18,927
|
$431,000 | — | 30 Jun 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
16,856
|
$400,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
12,718
|
$290,000 | — | 30 Jun 2021 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
12,497
|
$285,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
11,594
|
$264,000 | — | 30 Jun 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
9,372
|
$213,000 | — | 30 Jun 2021 | |
| Maven Securities LTD |
13F
|
Company |
0.01%
|
9,000
|
$210,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
4,372
|
$99,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,374
|
$54,000 | — | 30 Jun 2021 | |
| Capital Analysts, LLC |
13F
|
Company |
0%
|
750
|
$17,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
700
|
$16,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
54
|
$1,000 | — | 30 Jun 2021 |
Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q3 2021
As of 30 Sep 2021,
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,043,827 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, VIKING GLOBAL INVESTORS LP, BOXER CAPITAL, LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BVF INC/IL, and FRANKLIN RESOURCES INC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
32
Q3 2021 holders
43
Holder diff
11
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.